- Pioglitazone - (https://medlineplus.gov/druginfo/meds/a699016.html#:)
- Implications of Removing Rosiglitazone’s Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426122/#:)
- Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes - (https://clinicaltrials.gov/ct2/show/NCT01156597)
- A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control - (https://pubmed.ncbi.nlm.nih.gov/16914074/#:)
- Pioglitazone - (https://www.ncbi.nlm.nih.gov/books/NBK548327/#:)
Vogipax-MP (0.3mg/7.5mg/500mg) - Vidakem Lifesciences Pvt. Ltd.
Vogipax-MP (0.3mg/7.5mg/500mg) Tablet
Generic : Pioglitazone
When is Vogipax-MP (0.3mg/7.5mg/500mg) prescribed?
It is prescribed for -